TiGenix NV of Belgium said its application to the European Medicines Agency to launch a new cell-based product in Europe for cartilage repair is proceeding according to schedule. If approved, it would be launched at specialist centres in Europe. ---Subscribe to MedNous to access this article--- Company News
